Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT.
Nicola PolverelliEdouard F BonnevilleLiesbeth C de WreedeLinda KosterNicolaus Martin KrögerThomas SchroederRegis Peffault de LatourJakob PasswegKatja SockelAnnoek E C BroersAndrew ClarkPeter DregerDidier BlaiseIbrahim Yakoub-AghaSoeren Lykke PetersenJürgen FinkePatrice ChevallierGrzegorz HelbigWerner RabitschSimona SammassimoLuca ArcainiDomenico RussoJoanna Drozd-SokolowskaKavita RajMarie RobinGiorgia BattipagliaTomasz CzerwJuan Carlos Carlos Hernández-BoludaDonal P McLornanPublished in: American journal of hematology (2024)
Investigating the evaluation of eligibility for transplant in myelofibrosis (MF): The role of HCT-CI and BMI. HCT-CI emerges as a key prognostic factor, while BMI shows limited impact. This study expands insights for better clinical decision-making in MF allo-HCT.